The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with important stakeholders in the fight against fake medicines.
If we had the opportunity to deliver a statement at the 152nd WHO Executive Board meeting, this is what we would have said in relation to Agenda item 5. Universal Health Coverage Substandard & Falsified Read more…
We support and echo the statements delivered by our members on key agenda item 7. Substandard and falsified medical products (EB152/7) at the 152nd Executive Board Meeting of the World Health Organization. No more room Read more…
Fight the Fakes Alliance urges the international community to act now to prevent falsified and substandard medicines from reaching patients at risk via the global medicines supply chain. The 5th annual Fight the Fakes Week Read more…